Mazdutide: Better Than Ozempic?
Meet the "Dual Agonist." By combining GLP-1 with Glucagon, Mazdutide promises faster weight loss and better liver health than Semaglutide.
Table of Contents
What is Mazdutide ?
** Mazdutide(IBI362) ** is an investigational long - acting synthetic peptide that acts as a ** Dual Agonist ** for both: 1. ** GLP - 1 Receptor ** (Glucagon - Like Peptide - 1) 2. ** GCGR ** (Glucagon Receptor)
While Semaglutide(Ozempic) only hits the GLP - 1 brake pedal(stopping appetite), Mazdutide hits the GLP - 1 brake AND the Glucagon gas pedal(burning energy).This "Dual Agonism" mechanism is similar to the "Triple Agonism" of Retatrutide, but specifically focused on these two powerful pathways.
Mechanism: Why Add Glucagon ?
Targeting GLP - 1 suppresses appetite effectively.However, adding Glucagon receptor activation:
- ** Increases Energy Expenditure:** Glucagon signals the liver to release stored energy and increases thermogenesis(calorie burning).
- ** Protects the Liver:** Glucagon activity promotes the breakdown of liver fat, offering superior protection against Fatty Liver Disease(NAFLD).
Clinical Results(Phase 2 Data)
-
** Weight Loss:** Participants on 6mg of Mazdutide lost ** 15.4 %** of their body weight in 24 weeks.
* * Comparison: * This rivals the results of Tirzepatide(Mounjaro) and exceeds Semaglutide 2.4mg. -
** Liver Fat:** The dual mechanism showed a potent ability to strip fat from the liver, making it a leading candidate for treating ** NAFLD / NASH ** (Non - Alcoholic Fatty Liver Disease).
Dosing & Administration
- ** Frequency:** Once - weekly subcutaneous injection.
- ** Titration:** Like other GLP - 1s, patients must taper up slowly to mitigate nausea.
- Start: 1.5mg - 3.0mg.
- Target: 6.0mg - 9.0mg.
- ** Side Effects:** Nausea, diarrhea, and decreased appetite(similar to Ozempic, but potentially with slightly higher heart rate due to the Glucagon component).
Want to start a GLP-1 now?
Mazdutide is not approved in the US. The GLP-1 medicines a US clinician can prescribe today are semaglutide (Wegovy, Ozempic, Wegovy pill), tirzepatide (Zepbound, Mounjaro), liraglutide and oral orforglipron (Foundayo). Our sister site CalcMyPeptide compares what each route costs: insurance or Medicare, brand-name direct, and telehealth.
CalcMyPeptide is our sister site (same publisher, Kymata Labs). Its comparisons list only telehealth providers whose affiliate programs we have joined or applied to, and it may earn a commission. GLP-1 medicines need a prescription from a licensed clinician.